Skip to main content

Table 1 Clinical details of patients

From: No predialysis treatment of blood primes in pediatric continuous kidney replacement therapy

Case

1

2

3

4

5

6

7

8

Age

9 months

27 days

2 months

3 days

6 months

2 months

5 days

6 days

Sex

F

F

M

F

M

M

M

F

Weight (kg)

4.8

2.4

2.2

3.1

4.7

2.0

2.1

3.0

Underlying disease

TOF

TAPVC/PVO

TOF

HLHS

VSD

TOF

CoA/C

PA/IVS

VIS at admission

18.3

29.5

9.5

12.6

18

7

10

14.3

PELOD score at admission

22

30

12

21

20

12

20

22

PMR in terms of PELOD score

0.26

0.79

0.02

0.21

0.16

0.02

0.16

0.26

28-day outcome (the day of death)

Survival

Death (3)

Survival

Survival

Survival

Survival

Survival

Death (18)

90-day outcome

Survival

Survival

Survival

Survival

Survival

Survival

  1. TOF, tetralogy of Fallot; TAPVC, total anomalous pulmonary venous connection; PVO, pulmonary venous obstruction; HLHS, hypoplastic left heart syndrome; VSD, ventricular septal defect; CoA/C, coarctation complex; PA, pulmonary atresia; IVS, intraventricular septum; VIS, vasoactive inotropic score; PMR, predicted mortality rate; PELOD, pediatric logistic organ dysfunction